Skip to main content



) -- Shares of

Columbia Laboratories



) were gapping down Monday morning with an open price 12.3% lower than Friday's closing price. The stock closed at 73 cents Friday and opened today's trading at 64 cents.

The average volume for Columbia has been 1.6 million shares per day over the past 30 days. Columbia has a market cap of $78.5 million and is part of the

health care

sector and


industry. Shares are down 70.8% year to date as of the close of trading on Friday.

Columbia Laboratories, Inc. engages in the research, development, and commercialization of women's healthcare and endocrinology products. It develops products by utilizing its bioadhesive drug delivery technologies. The company has a P/E ratio of 5.6, below the average drugs industry P/E ratio of 11.3 and below the S&P 500 P/E ratio of 17.7.

Scroll to Continue

TheStreet Recommends

TheStreet Ratings rates Columbia as a


. The company's strengths can be seen in multiple areas, such as its notable return on equity, reasonable valuation levels and good cash flow from operations. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. You can view the full

Columbia Ratings Report


Get more investment ideas from our

investment research center


Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting


to 95370 or select from

multiple alert options